47045-COD-C-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria Congo (Democratic Republic), TB/HIV, United Nations Development Programme Goals: Contribuer à l'accéleration du progres vers la fin de l'épidemie de la TB en RDC / Contribute to accelerating progress towards the end of the TB epidemic in DRC; Faire de la RDC un pays avec « ZERO nouvelle infection, ZERO décès lié au VIH/Sida et ZERO discrimination et stigmatisation » dans la perspective qu’en RDC, le VIH ne soit plus un problème de santé Publique à l’horizon 2030. / To make the DRC a country with ZERO new infections, ZERO HIV/AIDS-related deaths, and ZERO discrimination and stigmatization so that by 2030, HIV will no longer be a public health problem in the DRC. Objectives: Dépister un total cumulé de 854 736 cas de TB toutes formes dans le cadre du GC7 parmi lequel 137 901 enfants et 6330 cas de TBMR / Screen a cumulative total of 854,736 cases of all forms of TB within the framework of GC7, including 137,901 children and 6,330 cases of MDR-TB; Traiter avec succès au moins 95% des patients TB PS notifiés et au moins 85 % des TB MR notifiés; / Successfully treat at least 95% of notified SP-TB patients and at least 85% of notified MDR-TB patients;; Mettre sous traitement d’infection latente enfants de moins de 5 ans en contact avec des cas TB+ exclue de la TB (352 801) ; / Put on treatment for latent infection children under 5 years of age in contact with TB+ cases excluded from TB (352,801);; Tester au VIH au moins 90% des patients tuberculeux notifiés durant la période ; / Test at least 90% of TB patients notified during the period for HIV;; Mettre sous ARV 95% des patients coïnfectés (TB VIH+) durant la période dans le pays ; / Put 95% of co-infected patients (HIV+ TB) on ARVs during the period in the country;; Réduire les nouvelles infections VIH de 95% d’ici 2027 / Reduce new HIV infections by 95% by 2027; Réduire les nouvelles infections chez les nourrissons nés des mères infectées par le VIH de 98 % d'ici 2027 / Reduce new infections among infants born to HIV-infected mothers by 98% by 2027; Réduire la mortalité liée au VIH de 9.5% à 7.4% / Reduce HIV-related mortality from 9.5% to 7.4% by the end of 2027; Reduire la discrimination, la stigmatisation et les inégalités sociales liées au VIH/TB à l’égard des PVVIH, populations clés (Transgenre, HSH, PS, UDI, PS, détenus ) et autres populations vulnérables (SVS, SVBG et OEV) de 95% d’ici fin 2027 / Reduce discrimination, stigma and social inequalities related to HIV/TB for PLHIV, key populations (Transgender, MSM, PS, IDU, PS, prisoners) and other vulnerable populations (SVS, SVBG and OVC) by 95% by the end of 2027; Soutenir la riposte nationale VIH par une bonne gouvernance et une coordination multisectorielle optimale à tous les niveaux d’ici à 2027 / Support the national HIV response through good governance and optimal multisectoral coordination at all levels by 2027. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Sonia Florisse Fund Portfolio Manager +41 58 791 1700 sonia.florisse@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Congo (Democratic Republic) HIV Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Differentiated HIV Testing Services -> Community-based testing outside of KP and AGYW programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs HIV -> Differentiated HIV Testing Services -> Self-testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs HIV -> Differentiated HIV Testing Services -> Self-testing outside of KP and AGYW programs HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Early infant diagnosis and follow-up HIV testing for exposed infants HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Post-natal infant prophylaxis HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM HIV -> Prevention package for other vulnerable populations (OVP) -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP HIV -> Prevention package for people in prisons and other closed settings -> Condom and lubricant programming for prisoners HIV -> Prevention package for people in prisons and other closed settings -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for prisoners HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Condom and lubricant programming for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> HIV prevention communication, information and demand creation for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Needle and syringe programs for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Opioid substitution therapy and other medically assisted drug dependence treatment for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Overdose prevention and management for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD HIV -> Prevention package for sex workers, their clients and other sexual partners -> Condom and lubricant programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers HIV -> Prevention package for transgender people and their sexual partners -> Condom and lubricant programming for transgender people HIV -> Prevention package for transgender people and their sexual partners -> HIV prevention communication, information and demand creation for transgender people HIV -> Prevention package for transgender people and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for transgender people HIV -> Prevention package for transgender people and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people HIV -> Prevention program stewardship -> Prevention program stewardship HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Multicomponent -> Program management -> Grant management RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Biosafety and biosecurity, infrastructure and equipment RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development RSSH -> RSSH: Health products management systems -> Planning and procurement capacity RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Data quality RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting Tuberculosis -> Collaboration with other providers and sectors -> Community-based TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Miners and mining communities Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - People in prisons/jails/detention centers Tuberculosis -> Removing human rights and gender related barriers to TB services -> Eliminating TB-related stigma and discrimination Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support Tuberculosis -> TB/DR-TB Prevention -> Infection prevention and control (IPC) Tuberculosis -> TB/HIV -> TB/HIV - Prevention Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis Tuberculosis -> TB/HIV -> TB/HIV - Treatment and care 1571338.51 73807884.44 64664619.95 42828746.00 Global Fund commitment to COD-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 42828746.00 Global Fund disbursement to COD-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 101894342.00 Global Fund commitment to COD-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5951605.00 Global Fund disbursement to COD-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 59650035.00 Global Fund disbursement to COD-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -36292702.00 Global Fund commitment to COD-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 0.00 Global Fund commitment to COD-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 21191461.00 Global Fund commitment to COD-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3183497.00 Global Fund disbursement to COD-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 14717018.57 Global Fund disbursement to COD-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 13712941.00 Global Fund commitment to COD-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -3290945.43 Global Fund commitment to COD-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 9255657.00 Global Fund disbursement to COD-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1571338.51 Expenditure reported by United Nations Development Programme for COD-C-UNDPP01, Oct 2024 to Dec 2024. United Nations Development Programme 58573215.77 Expenditure reported by United Nations Development Programme for COD-C-UNDPP01, Jan 2025 to Dec 2025. United Nations Development Programme An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Funding Request of funding request FR1493-COD-C. Funding Request of funding request FR1493-COD-C. Module: Differentiated HIV Testing Services. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 4942; Denominator: 81791. Numerator: 1853; Denominator: 124784. Numerator: 2881; Denominator: 124784. Numerator: 20344; Denominator: 128404. Numerator: 29792; Denominator: 128404. Numerator: 9591; Denominator: 128404. Numerator: 20344; Denominator: 128404. Numerator: 29792; Denominator: 128404. Numerator: 25139; Denominator: 132127. Numerator: 29063; Denominator: 132127. Module: Differentiated HIV Testing Services. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 2154; Denominator: 64672. Numerator: 808; Denominator: 110789. Numerator: 1462; Denominator: 110789. Numerator: 3952; Denominator: 114002. Numerator: 8214; Denominator: 114002. Numerator: 12826; Denominator: 114002. Numerator: 8214; Denominator: 114002. Numerator: 12826; Denominator: 114002. Numerator: 10150; Denominator: 117308. Module: Differentiated HIV Testing Services. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 9550; Denominator: 146462. Numerator: 3581; Denominator: 316993. Numerator: 6444; Denominator: 316993. Numerator: 22655; Denominator: 326184. Numerator: 51085; Denominator: 326184. Numerator: 56273; Denominator: 326184. Numerator: 51085; Denominator: 326184. Numerator: 56273; Denominator: 326184. Numerator: 63127; Denominator: 335645. Numerator: 72979; Denominator: 335645. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1125; Denominator: 1236; Percentage: 91.02%. Numerator: 1336; Denominator: 1403; Percentage: 95.22%. Numerator: 1336; Denominator: 1403; Percentage: 95.22%. Numerator: 67; Denominator: 1403; Percentage: 4.78%. Numerator: 67; Denominator: 1403; Percentage: 4.78%. Numerator: 540; Denominator: 1403; Percentage: 38.49%. Numerator: 540; Denominator: 1403; Percentage: 38.49%. Numerator: 0; Denominator: 1403; Percentage: 0%. Numerator: 0; Denominator: 1403; Percentage: 0%. Numerator: 863; Denominator: 1403; Percentage: 61.51%. Numerator: 863; Denominator: 1403; Percentage: 61.51%. Numerator: 1403; Denominator: 1403; Percentage: 100%. Numerator: 1403; Denominator: 1403; Percentage: 100%. Numerator: 1242; Denominator: 1242; Percentage: 100%. Numerator: 449; Denominator: 560; Percentage: 80.18%. Numerator: 432; Denominator: 449; Percentage: 96.21%. Numerator: 17; Denominator: 449; Percentage: 3.79%. Numerator: 190; Denominator: 449; Percentage: 42.32%. Numerator: 5. Numerator: 259; Denominator: 449; Percentage: 57.68%. Numerator: 444. Numerator: 1593; Denominator: 1593; Percentage: 100%. Numerator: 3186; Denominator: 3186; Percentage: 100%. Numerator: 1237; Denominator: 1384; Percentage: 89.38%. Numerator: 1593; Denominator: 1593; Percentage: 100%. Numerator: 554; Denominator: 632; Percentage: 87.66%. Numerator: 1188; Denominator: 1330; Percentage: 89.32%. Numerator: 49; Denominator: 154; Percentage: 31.82%. Numerator: 417; Denominator: 1237; Percentage: 33.71%. Numerator: 0. Numerator: 820; Denominator: 1237; Percentage: 66.29%. Numerator: 1237. Numerator: 2032; Denominator: 2032; Percentage: 100%. Numerator: 2032; Denominator: 2032; Percentage: 100%. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1056; Denominator: 1242. Numerator: 1174; Denominator: 1415. Numerator: 2708; Denominator: 3186. Numerator: 1836; Denominator: 2099. Numerator: 1354; Denominator: 1593. Numerator: 1354; Denominator: 1593. Numerator: 840; Denominator: 993. Numerator: 1727; Denominator: 2032. Numerator: 1727; Denominator: 2032. Module: Prevention package for men who have sex with men (MSM) and their sexual partners. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Module: Prevention package for men who have sex with men (MSM) and their sexual partners. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 5101; Denominator: 81791. Numerator: 1913; Denominator: 124784. Numerator: 3053; Denominator: 124784. Numerator: 20973; Denominator: 128404. Numerator: 28390; Denominator: 128404. Numerator: 9891; Denominator: 128404. Numerator: 20973; Denominator: 128404. Numerator: 28390; Denominator: 128404. Numerator: 25917; Denominator: 132127. Numerator: 29962; Denominator: 132127. Module: Prevention package for people who use drugs (PUD) and their sexual partners. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 2210; Denominator: 64672. Numerator: 829; Denominator: 110789. Numerator: 1500; Denominator: 110789. Numerator: 8214; Denominator: 114002. Numerator: 9404; Denominator: 114002. Numerator: 3980; Denominator: 114002. Numerator: 8214; Denominator: 114002. Numerator: 9404; Denominator: 114002. Numerator: 10150; Denominator: 117308. Numerator: 11734; Denominator: 117308. Module: Prevention package for sex workers, their clients and other sexual partners. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Module: Prevention package for sex workers, their clients and other sexual partners. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 9808; Denominator: 146462. Numerator: 3678; Denominator: 316993. Numerator: 6759; Denominator: 316993. Numerator: 51601; Denominator: 326184. Numerator: 66065; Denominator: 326184. Numerator: 22964; Denominator: 326184. Numerator: 51601; Denominator: 326184. Numerator: 66065; Denominator: 326184. Numerator: 63764; Denominator: 335645. Numerator: 73716; Denominator: 335645. Module: RSSH: Health products management systems. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 1976; Denominator: 2116. Numerator: 1289; Denominator: 2361. Numerator: 1665; Denominator: 2395. Numerator: 1665; Denominator: 2395. Module: RSSH: Health products management systems. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 3699; Denominator: 4044. Numerator: 1864; Denominator: 4076. Numerator: 4184; Denominator: 4750. Numerator: 4184; Denominator: 4750. Module: RSSH: Health products management systems. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 3211; Denominator: 3931. Numerator: 1421; Denominator: 4162. Numerator: 1412; Denominator: 2395. Numerator: 1412; Denominator: 2395. Module: TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 81154; Denominator: 253423. Numerator: 16563; Denominator: 69868. Numerator: 86754; Denominator: 280484. Numerator: 52699; Denominator: 141098.